Roche : Invitation to Roche’s virtual event on key Evrysdi data presented at the 2021 CureSMA Annual Meeting

Investor Update Invitation to Roche's virtual event on key Evrysdi data presented at the 2021 CureSMA Annual Meeting

We are pleased to invite investors and analysts to participate in our virtual event on Monday, 14 June 2021, highlighting Roche data presented during the congress scientific program from June 7 - 11 2021. 16:00 - 17:00 CEST / 15:00 - 16:00 BST 10:00 - 11:00 am EDT / 7:00 - 8:00 am PDT The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 3pm CEST on the day of the event. >click here Access to virtual event (pre-registration required) Please pre-register for our webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to [e-mail]. A replay of the webcast will be available via >ir.roche.com
Best regards, Karl Mahler Head of Investor Relations and Roche Group Planning	Gerard Tobin Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Jon Kaspar Bayard Phone: [phone] e-mail: [e-mail]
Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]	Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]
Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]	Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]	Dr. Lisa Tuomi Phone: [phone] e-mail: [e-mail]